Author & Content Reviewer Disclosures: The author and content reviewers of this educational activity have no relevant financial relationships to disclose with any commercial interests. All content has been reviewed for bias and balanced presentation of evidence-based information.
Commercial Support: This continuing education activity has received no commercial support.
Off-Label Use: This activity may contain discussion of published and/or investigational uses of agents not indicated by the FDA. MilenAi Digestive Health Consulting does not recommend the use of any agent outside of labeled indications. Please consult prescribing information for approved indications, contraindications, and warnings.
Disclaimer: The content and views presented are those of the authors and do not necessarily reflect those of MilenAi Digestive Health Consulting. This material is not intended as, and should not be used as, a substitute for clinical judgment.
Purpose & Learning Objectives
This continuing education activity provides gastroenterology and endoscopy nurses with a comprehensive understanding of moderate sedation pharmacology, including mechanisms of action, clinical applications, monitoring parameters, and reversal strategies for commonly used sedative and analgesic agents in the GI procedural setting.
Upon completion, you will be able to:
Differentiate between minimal, moderate, deep sedation, and general anesthesia according to the ASA sedation continuum
Describe the pharmacokinetic and pharmacodynamic properties of benzodiazepines, including midazolam, used in GI procedural sedation
Explain the mechanism of action, dosing considerations, and nursing implications for opioid analgesics, including fentanyl and meperidine
Analyze the role of propofol in nurse-administered propofol sedation (NAPS) programs, including patient selection criteria and safety protocols